ATE404581T1 - Faserformgebende peptide, die mit selbstanordnenden peptiden interagieren - Google Patents
Faserformgebende peptide, die mit selbstanordnenden peptiden interagierenInfo
- Publication number
- ATE404581T1 ATE404581T1 AT03793920T AT03793920T ATE404581T1 AT E404581 T1 ATE404581 T1 AT E404581T1 AT 03793920 T AT03793920 T AT 03793920T AT 03793920 T AT03793920 T AT 03793920T AT E404581 T1 ATE404581 T1 AT E404581T1
- Authority
- AT
- Austria
- Prior art keywords
- peptides
- self
- interact
- fiber forming
- assembling
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Multicomponent Fibers (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0220805.6A GB0220805D0 (en) | 2002-09-06 | 2002-09-06 | Peptide monomers and protein structures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE404581T1 true ATE404581T1 (de) | 2008-08-15 |
Family
ID=9943665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03793920T ATE404581T1 (de) | 2002-09-06 | 2003-09-08 | Faserformgebende peptide, die mit selbstanordnenden peptiden interagieren |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7507790B2 (de) |
| EP (1) | EP1534741B1 (de) |
| JP (1) | JP4544997B2 (de) |
| AT (1) | ATE404581T1 (de) |
| AU (1) | AU2003264736A1 (de) |
| DE (1) | DE60322913D1 (de) |
| DK (1) | DK1534741T3 (de) |
| GB (1) | GB0220805D0 (de) |
| WO (1) | WO2004022584A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201306634D0 (en) | 2013-04-11 | 2013-05-29 | Univ Bristol | Cage-like particles |
| JP6730705B2 (ja) * | 2015-02-12 | 2020-07-29 | 国立大学法人岩手大学 | 哺乳動物細胞に対する外来遺伝子の導入効率の向上剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5955343A (en) * | 1992-12-28 | 1999-09-21 | Massachusetts Institute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| GB9922013D0 (en) * | 1999-09-17 | 1999-11-17 | Univ Sussex | Peptides |
-
2002
- 2002-09-06 GB GBGB0220805.6A patent/GB0220805D0/en not_active Ceased
-
2003
- 2003-09-08 AT AT03793920T patent/ATE404581T1/de not_active IP Right Cessation
- 2003-09-08 DE DE60322913T patent/DE60322913D1/de not_active Expired - Lifetime
- 2003-09-08 EP EP03793920A patent/EP1534741B1/de not_active Expired - Lifetime
- 2003-09-08 AU AU2003264736A patent/AU2003264736A1/en not_active Abandoned
- 2003-09-08 WO PCT/GB2003/003900 patent/WO2004022584A1/en not_active Ceased
- 2003-09-08 DK DK03793920T patent/DK1534741T3/da active
- 2003-09-08 JP JP2004533672A patent/JP4544997B2/ja not_active Expired - Fee Related
- 2003-09-08 US US10/526,367 patent/US7507790B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003264736A1 (en) | 2004-03-29 |
| JP2006513985A (ja) | 2006-04-27 |
| DE60322913D1 (de) | 2008-09-25 |
| EP1534741A1 (de) | 2005-06-01 |
| DK1534741T3 (da) | 2008-12-15 |
| WO2004022584A1 (en) | 2004-03-18 |
| US20060155112A1 (en) | 2006-07-13 |
| JP4544997B2 (ja) | 2010-09-15 |
| GB0220805D0 (en) | 2002-10-16 |
| US7507790B2 (en) | 2009-03-24 |
| EP1534741B1 (de) | 2008-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2020016I1 (no) | efmoroktokog alfa - forlenget SPC | |
| EE200300264A (et) | ß-amüloidpeptiidi äratundvad humaniseeritud antikehad | |
| ATE454393T1 (de) | Egvii-endoglucanase und dafür codierende nukleinsäuren | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| ATE444969T1 (de) | Dimerisiertes peptid | |
| EP1613261A4 (de) | Intrazelluläre bildung von peptidkonjugaten | |
| MXPA04003333A (es) | Remodelado y glicoconjugacion de peptidos. | |
| DK1423419T3 (da) | Hybrid- og tandemekspression af Neisseria-proteiner | |
| ATE428727T1 (de) | Neue, an den erythropoietinrezeptor bindende peptide | |
| ATE411082T1 (de) | Neue verwendung von kurzkettigen carbonsäuren | |
| EP1499352A4 (de) | Rekombinante anti-interleukin-9-antikörper | |
| HUP9802212A2 (hu) | Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok | |
| WO2003074546A3 (de) | Streptavidin-bindungspeptid | |
| DE60327407D1 (de) | Immunmodulierende peptide | |
| ATE489401T1 (de) | Pegyliertes t20-polypeptid | |
| EA200600042A1 (ru) | Способы образования дисульфидных связей и гликозилирования белков и реагенты, применяемые в этих способах | |
| ATE323722T1 (de) | Antimikrobiell wirkendes peptid | |
| DE60039049D1 (de) | Erhöhte expression von proteinen mittels gfp | |
| ATE404581T1 (de) | Faserformgebende peptide, die mit selbstanordnenden peptiden interagieren | |
| DK1368372T3 (da) | Peptid med affinitet til det virale gp120-protein samt anvendelse deraf | |
| EA200400392A1 (ru) | Связывающий каспазу-8 белок, его получение и применение | |
| NO20032963L (no) | Peptidforbindelser | |
| EP1411964A4 (de) | Die blutgerinnung modulierende peptide und ihre verwendungszwecke | |
| EA200200598A1 (ru) | Генная терапия вич-инфицированных путем экспрессии заякоренных на мембране пептидов gp41 | |
| NO20044105L (no) | VEGF peptider og anvendelse derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |